Tue, 19 Nov 2019 15:49:39: Sorry, Shkreli: Supreme Court rebuffs ex-pharma CEO's final appeal

Tue, 19 Nov 2019 14:49:57: Merck, Bayer's trial win for heart failure rival could actually boost Novartis' Entresto

Tue, 19 Nov 2019 14:47:12: Novartis, Merck KGaA and Biogen: Which new MS drug do doctors like best? You might be surprised

Tue, 19 Nov 2019 14:05:43: Hit by copycat meds, Amgen trims 172 more jobs, this time in operations, R&D and sales

Mon, 18 Nov 2019 16:01:08: Pfizer scores FDA nod for biosim to AbbVie's Humira, but it'll have to wait til 2023 to launch

Mon, 18 Nov 2019 15:02:45: Recipharm bolsters its inhalation and injectables manufacturing with $650M deal for Consort Medical

Mon, 18 Nov 2019 14:41:27: Oklahoma judge chops $107M from Johnson & Johnson's opioid verdict

Mon, 18 Nov 2019 13:31:25: AHA: Amarin's Vascepa halts progression of arterial plaque in key study

Sun, 17 Nov 2019 23:56:14: Sanofi and Regeneron's medical congress campaign focuses on type 2 inflammation education for docs

Sun, 17 Nov 2019 18:07:20: AHA: Amgen's Repatha tied to greater risk reduction in high-risk heart attack patients

Sun, 17 Nov 2019 15:36:39: AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds

Sun, 17 Nov 2019 00:20:58: AHA: AstraZeneca's Brilinta linked to less bleeding solo than as an aspirin add-on

Sat, 16 Nov 2019 20:10:05: AHA: Johnson & Johnson, Bayer still looking for answers in aborted Xarelto study

Sat, 16 Nov 2019 18:04:31: AHA: Novartis hoping for 2nd go at broader use with 'profound' Entresto subdata

Sat, 16 Nov 2019 16:49:25: Pfizer, BMS look to early atrial fibrillation screening for potential Eliquis boost

Sat, 16 Nov 2019 03:49:14: AHA: AstraZeneca's Farxiga outcomes data look even better in patients without diabetes

Fri, 15 Nov 2019 16:09:19: Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move

Fri, 15 Nov 2019 16:01:37: FiercePharmaPolitics—Trump says international pricing plan not 'satisfactory,' pushes for even lower costs

Fri, 15 Nov 2019 15:12:02: FDA approves Shionogi's antibiotic Fetroja with spooky mortality warning label

Fri, 15 Nov 2019 14:58:05: FiercePharmaAsia—Sandoz bets, Lupin sells in Japan; Dr. Reddy's Zantac loss; Aslan's varlitinib flop

Fri, 15 Nov 2019 14:51:34: Some Dollar Tree OTC products came from Chinese plant littered with 'rodent feces,' FDA says

Fri, 15 Nov 2019 13:25:27: GlaxoSmithKline's Shingrix supply will vault upward, CEO says—in 2024, that is

Fri, 15 Nov 2019 12:31:25: BeiGene nabs landmark FDA nod for Brukinsa, kicking off challenge against blockbuster Imbruvica

Thu, 14 Nov 2019 22:51:23: 'Agency overreach, plain and simple': Drugmakers hit back at HHS as drug prices in TV ads get another hearing

Thu, 14 Nov 2019 21:32:29: Blockbuster in sight? Amarin's Vascepa sails through FDA panel vote toward new CV nod